心臓血管疾患における遺伝学的検査と遺伝カウ ... - 日本循環器学会

循 環 器 病 の 診 断 と 治 療 に 関 するガイドライン(2010 年 度 合 同 研 究 班 報 告 )fibrillation. Am J Hum Genet 2004; 75: 899-905.197. Gussak I, Brugada P, Brugada J, et al. Idiopathic short QTinterval: a new clinical syndrome? Cardiology 2000; 94: 99-102.198. Bjerregaard P, Gussak I. Short QT syndrome. AnnNoninvasive Electrocardiol 2005; 10: 436-440.199. Priori SG, Pandit SV, Rivolta I, et al. A novel form of shortQT syndrome (SQT3) is caused by a mutation in the KCNJ2gene. Circ Res 2005; 96: 800-807.200. Gaita F, Giustetto C, Bianchi F, et al. Short QT Syndrome:a familial cause of sudden death. Circulation 2003; 108: 965-970.201. Brugada R, Hong K, Dumaine R, et al. Sudden deathassociated with short-QT syndrome linked to mutations inHERG. Circulation 2004; 109: 30-35.202. Bellocq C, van Ginneken AC, Bezzina CR, et al. Mutationin the KCNQ1 gene leading to the short QT-intervalsyndrome. Circulation 2004; 109: 2394-2397.203. Leenhardt A, Lucet V, Denjoy I, et al. Catecholaminergicpolymorphic ventricular tachycardia in children. A 7-yearfollow-up of 21 patients. Circulation 1995; 91: 1512-1519.204. Priori SG, Napolitano C, Memmi M, et al. Clinical andmolecular characterization of patients with catecholaminergicpolymorphic ventricular tachycardia. Circulation 2002; 106:69-74.205. Viatchenko-Karpinski S, Terentyev D, Gyorke I, et al.Abnormal calcium signaling and sudden cardiac deathassociated with mutation of calsequestrin. Circ Res 2004; 94:471-477.206. Benson DW, Wang DW, Dyment M, et al. Congenital sicksinus syndrome caused by recessive mutations in the cardiacsodium channel gene (SCN5A). J Clin Invest 2003; 112:1019-1028.207. Veldkamp MW, Viswanathan PC, Bezzina C, et al. Twod i s t i n c t c o n g e n i t a l a r r h y t h m i a s e v o k e d b y amultidysfunctional Na (+) channel. Circ Res 2000; 86: E91-97.208. Baroudi G, Chahine M. Biophysical phenotypes of SCN5Amutations causing long QT and Brugada syndromes. FEBSLett 2000; 487: 224-228.209. Rivolta I, Abriel H, Tateyama M, et al. Inherited Brugadaand long QT-3 syndrome mutations of a single residue of thecardiac sodium channel confer distinct channel and clinicalphenotypes. J Biol Chem 2001; 276: 30623-30630.210. Bezzina C, Veldkamp MW, van Den Berg MP, et al. Asingle Na (+) channel mutation causing both long-QT andBrugada syndromes. Circ Res 1999; 85: 1206-1213.211. Grant AO. Molecular biology of sodium channels and theirrole in cardiac arrhythmias. Am J Med 2001; 110: 296-305.212. Viswanathan PC, Balser JR. Inherited sodiumchannelopathies: a continuum of channel dysfunction. TrendsCardiovasc Med 2004; 14: 28-35.213. Tan HL, Bink-Boelkens MT, Bezzina CR, et al. A sodiumchannelmutation causes isolated cardiac conduction disease.Nature 2001; 409: 1043-1047.214. Lifton RP, Gharavi AG, Geller DS. Molecular mechanismsof human hypertension. Cell 2001; 104: 545-556.215. Hansson JH, Nelson-Williams C, Suzuki H, et al.Hypertension caused by a truncated epithelial sodium channelgamma subunit: genetic heterogeneity of Liddle syndrome.Nat Genet 1995; 11: 76-82.216. Hansson JH, Schild L, Lu Y, et al. A de novo missensemutation of the beta subunit of the epithelial sodium channelcauses hypertension and Liddle syndrome, identifying aproline-rich segment critical for regulation of channel activity.Proc Natl Acad Sci U S A. 1995; 92: 11495-11499.217. Schild L, Canessa CM, Shimkets RA, et al. A mutation inthe epithelial sodium channel causing Liddle disease increaseschannel activity in the Xenopus laevis oocyte expressionsystem. Proc Natl Acad Sci U S A. 1995; 92: 5699-5703.218. Mune T, Rogerson FM, Nikkila H, et al. Humanhypertension caused by mutations in the kidney isozyme of11 beta-hydroxysteroid dehydrogenase. Nat Genet 1995; 10:394-399.219. Abbott EC, Gornall AG, Sutherland DJ, et al. The influenceof a heparin-like compound on hypertension, electrolytes andaldosterone in man. Can Med Assoc J 1966; 94: 1155-1164.220. Sutherland DJ, Ruse JL, Laidlaw JC. Hypertension,increased aldosterone secretion and low plasma renin activityrelieved by dexamethasone. Can Med Assoc J 1966; 95:1109-1119.221. Lifton RP, Dluhy RG, Powers M, et al. Hereditaryhypertension caused by chimaeric gene duplications andectopic expression of aldosterone synthase. Nat Genet 1992;2: 66-74.222. Wilson FH, Disse-Nicodeme S, Choate KA, et al. Humanhypertension caused by mutations in WNK kinases. Science2001; 293: 1107-1112.223. Mansfield TA, Simon DB, Farfel Z, et al. Multilocuslinkage of familial hyperkalaemia and hypertension,pseudohypoal-dosteronism type II, to chromosomes 1q31-42and 17p11-q21. Nat Genet 1997; 16: 202-205.224. Geller DS, Farhi A, Pinkerton N, et al. Activating mineralocorticoidreceptor mutation in hypertension exacerbated bypregnancy. Science 2000; 289: 119-123.225. Wilson FH, Hariri A, Farhi A, et al. A cluster of metabolicdefects caused by mutation in a mitochondrial tRNA. Science2004; 306: 1190-1194.226. Choi M, Scholl UI, Yue P, et al. K+ channel mutations inadrenal aldosterone-producing adenomas and hereditaryhypertension. Science 2011; 331: 768-772.227. Shea S, Ottman R, Gabrieli C et al. Family history as anindependent risk factor for coronary artery disease. J Am CollCardiol 1984; 4; 793-801.228. Rissanen AM. Familial occurrence of coronary heartdisease: effect of age at diagnosis. Am J Cardiol 1979; 44: 60-66.229. The international HapMap Consortium. The international48